Ferris Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ferris Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$330K	Buy	3,672 +1,367	+59%	+$126K	0.08%	158
2021 Q4	$258K	Hold	2,305	–	–	0.06%	177
2021 Q3	$291K	Buy	+2,305	New	+$297K	0.06%	177
2021 Q2	–	Sell	-2,305	Closed	-$313K	–	199
2021 Q1	$313K	Hold	2,305	–	–	0.08%	162
2020 Q4	$325K	Buy	+2,305	New	+$295K	0.09%	149
2019 Q2	–	Sell	-200	Closed	-$18K	–	625
2019 Q1	$18K	Hold	200	–	–	0.01%	376
2018 Q4	$14K	Hold	200	–	–	0.01%	392
2018 Q3	$19K	Hold	200	–	–	0.01%	375
2018 Q2	$19K	Hold	200	–	–	0.01%	375
2018 Q1	$18K	Buy	+200	New	+$18.3K	0.01%	417

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Ferris Capital's XBI Position: Q1 2022 in Review

Ferris Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 59% in Q1 2022, buying an estimated $126K and bringing the position to 3,672 shares worth $330K. The position accounts for 0.08% of the portfolio, ranked #158.

Ferris Capital first reported a position in XBI in Q1 2018 and has held it in 10 quarters since. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Ferris Capital held 3,672 shares of State Street SPDR S&P Biotech ETF worth $330K as of Q1 2022.
Ferris Capital bought 1,367 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $126K.
State Street SPDR S&P Biotech ETF made up 0.08% of Ferris Capital's portfolio in Q1 2022, its #158 holding.
Ferris Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 10 quarters since.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.